StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
Huagongshe Open Project:[email protected]KI-Anbindung: llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.7.8
  1. Startseite
  2. /Verbindung

2,4'-Dichlorobiphenyl

HCID 36982
NotizenReaktionen
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
34883-43-7
Standard-SMILES
Clc1ccc(-c2ccccc2Cl)cc1
InChIKey
UFNIBRDIUNVOMX-UHFFFAOYSA-N
Summenformel
C12H8Cl2
Durchschnittliche Molmasse
223,09 g/mol
Monoisotopische Masse
222,0003056

Überblick

2,4'-dichlorobiphenyl is a dichlorobiphenyl that is chlorobenzene in which the hydrogen at position 2 has been replaced by a 4-chlorophenyl group. It is a dichlorobiphenyl and a member of monochlorobenzenes.

Namen und Bezeichner

Bevorzugter Name
2,4'-Dichlorobiphenyl
IUPAC
1-chloro-2-(4-chlorophenyl)benzene
Englischer Name
2,4'-Dichlorobiphenyl
Summenformel
C12H8Cl2
Molmasse
223.1

Namen und Synonyme

2,4'-DICHLOROBIPHENYL34883-43-72,4'-Dichloro-1,1'-biphenylPCB 81,1'-Biphenyl, 2,4'-dichloro-DTXSID0022511TTP086070WCHEBI:342321-chloro-4-(2-chlorophenyl)benzeneRefChem:53554681-934-1DTXCID902511
Weitere Namen anzeigen
BZNO 82,4'-CBPCB NO 8C20000800 PCB No. 8Hexanal Impurity 242,4’-dichloro-bipheny2,4’-dichloro-1’-biphenyl
1-chloro-2-(4-chlorophenyl)benzenePCB No. 8Biphenyl, 2,4'-dichloro-CHEMBL1958902,4'-DICHLOROBIPHENYL (IUPAC N.8) (purity)2,4/'-DichlorobiphenylBRN 1946417UNII-TTP086070W

Datenbank-Bezeichner

CAS
34883-43-7
PubChem CID
36982
DTXSID
DTXSID0022511
ChEMBL
CHEMBL195890
ChEBI
CHEBI:34232
UNII
TTP086070W
EC Number

Eigenschaften

Berechnete Struktureigenschaften

XLogP
5,1
Polarare Oberfläche (TPSA)
0 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
0
Frei drehbare Bindungen
1
Schwere Atome
14
Formalladung
0
Komplexität
173

Experimentelle und physikochemische Eigenschaften

SpringerMaterials Properties13C nuclear magnetic resonance spectrum
LogP5.09
Endocrine DisruptorsPotential endocrine disrupting compound
Collision Cross Section141 Ų [M]+ [CCS Type: TIMS, Method: calibration with PAHs]

Physikochemische Eigenschaften

Schmelzpunkt
46 °C · 46°C
Siedepunkt
289.78 °C · 289.78°C (rough estimate)
Dichte
1.249 · 1.2490 (rough estimate)
Brechungsindex
1.594 · 1.5940 (rough estimate)
storage temp.
Sealed in dry,Room Temperature
Wasserlöslichkeit
0.62 mg/L · 0.62mg/L(25 ºC)
BRN
1946417 · 1946417
Henry's Law Constant
3.8 · 3.8×10-2 mol/(m3Pa) at 25℃, Li et al. (2003)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 6 Einträge

Warning

H373 (100%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]

P260, P273, P319, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Warning

H350 (100%): May cause cancer [Danger Carcinogenicity]

Gefahrenhinweise

Regulatory InformationSubstance: 2,4-PCB
Hazard Classes and Categories · 2 Einträge

Carc. 1B (100%)

STOT RE 2 (100%)

Sicherheit und Schutzausrüstung

Minimum Risk LevelIntermediate Oral: 0.03 ug/kg/day (L134)

Toxikologische Informationen

Treatment · 1 Eintrag

There are no specific treatments for PCB poisoning, since it is not usually recognized until after substantial chronic exposure. Only preventing further exposure and treating the observed symptoms can be done. Acute inhalation can be treated by administering oxygen. (L4)

Health Effects · 1 Eintrag

The most common health effects of PCBs are skin conditions such as chloracne and rashes. Chronic PCB exposure has also been shown to cause liver, stomach and kidney, damage, jaundice, edema, anemia, changes in the immune system, behavioral alterations, and impaired reproduction. (L4)

Chemie und Industrie

Pharmakologische Informationen

Metabolism/Metabolites · 1 Eintrag

PCBs are absorbed via inhalation, oral, and dermal routes of exposure. They are trasported in the blood, often bound to albumin. Due to their lipophilic nature they tend to accumulate in lipid-rich tissues, such as the liver, adipose, and skin. Metabolism of PCBs is very slow and varies based on the degree and position of chlorination. PCBs are metabolized by the microsomal monooxygenase system catalyzed by cytochrome P-450 enzymes to polar metabolites that can undergo conjugation with glutathione and glucuronic acid. The major metabolites are hydroxylated products which are excreted in the bile and faeces. The slow metabolism of PCBs means they tend to accumulate in body tissues. (L4, T6)

Verwendung und Herstellung

Uses · 1 Eintrag

PCBs were used as coolants and lubricants in transformers, capacitors, and other electrical devices (such as fluorescent lights and refridgerators) produced before 1977. PCBs may contaminate the air and water near hazardous waste sites. In addition, PCBs bioaccumulate in the environment and may be found in fish, meat, and dairy products. (L4)

Anwendungen

Verwenden2,4''-Dichlorobiphenyl is a polychlorinated biphenyl (PCB) congeners.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

2,4-Dichlorobiphenyl2,4,4'-Trichlorbiphenyl4,4'-Dichlorbiphenyl

Anbieter42 Anbieter

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen

Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
681-934-1、684-162-3
Nikkaji
J88.975J
EPA chemische Informationen
2 · 2,4'-Dichlorobiphenyl (34883-43-7)
Exposure RoutesOral (L4) ; inhalation (L4) ; dermal (L4)
Toxicity Summary · 1 Eintrag

The mechanism of action varies with the specific PCB. Dioxin-like PCBs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic Phase I and Phase II enzymes, especially of the cytochrome P450 family. Most of the toxic effects of PCBs are believed to be results of Ah receptor binding. Other PBCs are believed to interfere with calcium channels and/or change brain dopamine levels. PCBs can also cause endocrine disurption by altering the production of thyroid hormones and binding to estrogen receptors, which can stimulate the growth of certain cancer cells and produce other estrogenic effects, such as reproductive dysfunction. They will bioaccumulate by binding to receptor proteins such as uteroglobin. (A3, A4, A30, A66)

Signs and SymptomsChronic PCB exposure results in symptoms such as abdominal pain, nausea, vomiting, diarrhea, headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3)
Carcinogen Classification1, carcinogenic to humans. (L135)
Toxicity DataLD50: 1010 mg/kg (Oral, Rat) (T14) LD50: 880 mg/kg (Intraperitoneal, Mouse) (T14)

Sicherheitsdaten

wgk
3
ridadr
UN 3432 9/PG 2
RTECS-Nr.
DV3905000
risk_code
33-50/53
hazard_code
N,Xn
safety_code
35-60-61
陕西缔都医药有限责任公司029-81124775 17791530730 · [email protected]
阿诺西(上海)生物技术有限公司400-1107768 15058188853 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
盐城通铭生物科技有限公司15195160625 · [email protected]
毕佳索(上海毕得医药科技股份有限公司)400-6005915 · [email protected]
江苏智芯廷科技有限公司18221391031 · [email protected]
河南赢创生物科技有限公司16650615803 · [email protected]
上海腾准生物科技有限公司19821570922 · [email protected]
安徽合诺生物科技有限公司0555-2761852
北京索莱宝科技有限公司010-50973130 17801761073 · [email protected]
梯希爱(上海)化工贸易有限公司021-61109150 · [email protected]
广东方信生物科技有限公司0751-2838688 13376594225 · [email protected]
安徽合诺生物科技有限公司18455579438
上海艾梯西生物科技有限公司18721763493 · [email protected]
上海稳同科技有限公司02151600108 13062666369 · [email protected]
上海毕楷科技有限公司18516304666 · [email protected]
山东西亚化学有限公司13355009207 13355009207 · [email protected]
上海耐士化工科技有限公司400-188-0725 +86 21 34310725 13611771617
上海源叶生物科技有限公司18916372613 · [email protected]
江苏艾康生物医药研发有限公司025-66113011 13913916777 · [email protected]
天津阿尔塔科技有限公司022-65378550-8551 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海御略医药科技有限公司021-60345187 13671753212 · [email protected]
天津阿尔塔科技有限公司022-6537-8550 15522853686 · [email protected]
成都华纯科技有限公司400-1166-196 15982826727 · [email protected]
Shanghai Acmec Biochemical Technology Co., Ltd.+86-18621343501 · [email protected]
Shaanxi Didu New Materials Co. Ltd+86-86-17392712779 +86-13289823923 · [email protected]
上海臻励生物科技有限公司021-16621358918; 18516310516;16621358918;13045646768 · [email protected]
武汉赢元贝商贸有限公司86-13349903920 13349903920 · [email protected]
广东翁江化学试剂有限公司0751-2815688 13927872512 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
Aladdin Scientific[email protected]
上海皓鸿生物医药科技有限公司400-8210725 4008210725 · [email protected]
广东元丰化学试剂有限公司0751-2829979 13318584237 · [email protected]
SHANGHAI KEAN TECHNOLOGY CO., LTD.+8613817748580 · [email protected]
青岛腾龙微波科技有限公司0532-83818797 17669478191 · [email protected]
SUZHOU SENFEIDA CHEMICAL CO.,LTD+86-0512-83500002 +86-15195660023 · [email protected]
上海捷世凯生物科技有限公司021-57520305 13795461237 · [email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]
Hefei TNJ Chemical Industry Co.,Ltd.+86-0551-65418671 +86-189 4982 3763 · [email protected]
珠海奥博凯生物医药技术有限公司400-0628126 · [email protected]
河南威梯希化工科技有限公司0371-55135753 18003832934 · [email protected]

Ergänzende Hinweise

DefinitionChEBI: A dichlorobiphenyl that is chlorobenzene in which the hydrogen at position 2 has been replaced by a 4-chlorophenyl group.